日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Haloarcula marismortui Replication factor C large subunit (rfcL), partial CSB-YP736170HTJ
CSB-EP736170HTJ
CSB-BP736170HTJ
CSB-MP736170HTJ
CSB-EP736170HTJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloarcula marismortui Tritrans,polycis-undecaprenyl-diphosphate synthase (GGDP specific) (uppS) CSB-YP736171HTJ
CSB-EP736171HTJ
CSB-BP736171HTJ
CSB-MP736171HTJ
CSB-EP736171HTJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloarcula marismortui DNA-directed RNA polymerase subunit P (rpoP) CSB-YP736172HTJ
CSB-EP736172HTJ
CSB-BP736172HTJ
CSB-MP736172HTJ
CSB-EP736172HTJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloarcula marismortui Orotidine 5'-phosphate decarboxylase (pyrF) CSB-YP736173HTJ
CSB-EP736173HTJ
CSB-BP736173HTJ
CSB-MP736173HTJ
CSB-EP736173HTJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloarcula marismortui Adenylosuccinate synthetase (purA) CSB-YP736174HTJ
CSB-EP736174HTJ
CSB-BP736174HTJ
CSB-MP736174HTJ
CSB-EP736174HTJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloarcula marismortui Probable cobyrinic acid A,C-diamide synthase (cobB) CSB-YP736175HTJ
CSB-EP736175HTJ
CSB-BP736175HTJ
CSB-MP736175HTJ
CSB-EP736175HTJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloarcula marismortui 3-methyl-2-oxobutanoate hydroxymethyltransferase (panB) CSB-YP736176HTJ
CSB-EP736176HTJ
CSB-BP736176HTJ
CSB-MP736176HTJ
CSB-EP736176HTJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloarcula marismortui 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase (menD), partial CSB-YP736177HTJ
CSB-EP736177HTJ
CSB-BP736177HTJ
CSB-MP736177HTJ
CSB-EP736177HTJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloarcula marismortui Methylaspartate mutase S chain 1 (mamA1) CSB-YP736178HTJ
CSB-EP736178HTJ
CSB-BP736178HTJ
CSB-MP736178HTJ
CSB-EP736178HTJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloarcula marismortui Type II DNA topoisomerase VI subunit A (top6A) CSB-YP736179HTJ
CSB-EP736179HTJ
CSB-BP736179HTJ
CSB-MP736179HTJ
CSB-EP736179HTJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloarcula marismortui Histidinol dehydrogenase (hisD) CSB-YP736180HTJ
CSB-EP736180HTJ
CSB-BP736180HTJ
CSB-MP736180HTJ
CSB-EP736180HTJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloarcula marismortui Proline--tRNA ligase (proS) CSB-YP736181HTJ
CSB-EP736181HTJ
CSB-BP736181HTJ
CSB-MP736181HTJ
CSB-EP736181HTJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloarcula marismortui Anthranilate synthase component 1 3 (trpE3), partial CSB-YP736182HTJ
CSB-EP736182HTJ
CSB-BP736182HTJ
CSB-MP736182HTJ
CSB-EP736182HTJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Botryotinia fuckeliana pH-response regulator protein palH/RIM21 (palH), partial CSB-YP736183BVD1
CSB-EP736183BVD1
CSB-BP736183BVD1
CSB-MP736183BVD1
CSB-EP736183BVD1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cat Allergen Fel d 4 CSB-YP736184CA
CSB-BP736184CA
CSB-MP736184CA
CSB-EP736184CA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nycticebus pygmaeus Cytochrome b (MT-CYB), partial CSB-YP736185NBAU
CSB-EP736185NBAU
CSB-BP736185NBAU
CSB-MP736185NBAU
CSB-EP736185NBAU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lepilemur ruficaudatus Cytochrome b (MT-CYB), partial CSB-YP736186LCAS
CSB-EP736186LCAS
CSB-BP736186LCAS
CSB-MP736186LCAS
CSB-EP736186LCAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Subtilisin-like protease 6 (SUB6) CSB-YP736187TBAV
CSB-EP736187TBAV
CSB-BP736187TBAV
CSB-MP736187TBAV
CSB-EP736187TBAV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Opistophthalmus carinatus Opistoporin-4 CSB-YP736188OBW
CSB-EP736188OBW
CSB-BP736188OBW
CSB-MP736188OBW
CSB-EP736188OBW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant West Caucasian bat virus Phosphoprotein (P) CSB-YP736189WAAC
CSB-EP736189WAAC
CSB-BP736189WAAC
CSB-MP736189WAAC
CSB-EP736189WAAC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×